
    
      Subjects with schizophrenia will be recuited from several sub-centers. The relevant gene
      polymorphisms and risperidone drug metabolism, drug adverse reaction parameters are monitored
      through drawing blood samples at 0h, 6h, D27 and D56 of the risperidone drug administration.
      Information related to drug pharmacokinetics, pharmacodynamics and adverse reactions(serum
      prolactin levels) will be collected and analyzed.
    
  